However, in other non-stroke patient cohorts seropositivity was associated with cognitive impairment in melanoma patients, and iserum IgA was found to be associated with different types of slowly progressive cognitive impairment [4, 6, 7]. This evidence concerns the gene CD79A and melanoma.